• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2016 Fiscal Year Final Research Report

Development of a topical drug for ocular neovascularization using an novel SRPK inhibitor

Research Project

  • PDF
Project/Area Number 15K20257
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Ophthalmology
Research InstitutionKyoto University

Principal Investigator

MOROOKA SATOSHI  京都大学, 医学研究科, 特定助教 (80738005)

Research Collaborator YOSHIMURA Nagahisa  京都大学, 大学院院医学研究科眼科, 教授
HAGIWARA Masatoshi  京都大学, 大学院医学研究科形態形成機構学, 教授
HOSOYA Takamitsu  東京医科歯科大学, 生体材料工学研究所, 教授
Project Period (FY) 2015-04-01 – 2017-03-31
Keywords血管新生阻害
Outline of Final Research Achievements

Intravitreous injection of anti-VEGF antibodies has been demonstrated to cure intraocular neovascularization. We developed an eye ointment containing new SRPK inhibitor to reduce the risk of several complications by intraocular injection. In a mouse model of laser-induced choroidal neovascularization, topical administration of eye ointment containing SRPK inhibitor significantly inhibited choroidal neovascularization than that of control ointment. We tried to make a pro-drug of the SRPK inhibitor that is more efficient. We synthesized that compound in large quantity and got an acetylated derivative of the SRPK inhibitor referring to previous report.

Free Research Field

眼科

URL: 

Published: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi